Cloprostenol Sodium Injection Market Report – Research, Industry Analysis Reports and Market Demands

Global Cloprostenol Sodium Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Cloprostenol Sodium Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 20ml/vial
- 1.3.3 100ml/vial
- 1.3.4 Others
1.4 Market Analysis by Specification
- 1.4.1 Overview: Global Cloprostenol Sodium Injection Consumption Value by Specification: 2021 Versus 2025 Versus 2032
- 1.4.2 250 µg/mL
- 1.4.3 100 µg/mL
1.5 Market Analysis by Application
- 1.5.1 Overview: Global Cloprostenol Sodium Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.5.2 Cows
- 1.5.3 Ewes
- 1.5.4 Sows
- 1.5.5 Others
1.6 Global Cloprostenol Sodium Injection Market Size & Forecast
- 1.6.1 Global Cloprostenol Sodium Injection Consumption Value (2021 & 2025 & 2032)
- 1.6.2 Global Cloprostenol Sodium Injection Sales Quantity (2021-2032)
- 1.6.3 Global Cloprostenol Sodium Injection Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Cloprostenol Sodium Injection by Manufacturer

3.1 Global Cloprostenol Sodium Injection Sales Quantity by Manufacturer (2021-2026)
3.2 Global Cloprostenol Sodium Injection Revenue by Manufacturer (2021-2026)
3.3 Global Cloprostenol Sodium Injection Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Cloprostenol Sodium Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Cloprostenol Sodium Injection Manufacturer Market Share in 2025
- 3.4.3 Top 6 Cloprostenol Sodium Injection Manufacturer Market Share in 2025
3.5 Cloprostenol Sodium Injection Market: Overall Company Footprint Analysis
- 3.5.1 Cloprostenol Sodium Injection Market: Region Footprint
- 3.5.2 Cloprostenol Sodium Injection Market: Company Product Type Footprint
- 3.5.3 Cloprostenol Sodium Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Cloprostenol Sodium Injection Market Size by Region
- 4.1.1 Global Cloprostenol Sodium Injection Sales Quantity by Region (2021-2032)
- 4.1.2 Global Cloprostenol Sodium Injection Consumption Value by Region (2021-2032)
- 4.1.3 Global Cloprostenol Sodium Injection Average Price by Region (2021-2032)
4.2 North America Cloprostenol Sodium Injection Consumption Value (2021-2032)
4.3 Europe Cloprostenol Sodium Injection Consumption Value (2021-2032)
4.4 Asia-Pacific Cloprostenol Sodium Injection Consumption Value (2021-2032)
4.5 South America Cloprostenol Sodium Injection Consumption Value (2021-2032)
4.6 Middle East & Africa Cloprostenol Sodium Injection Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Cloprostenol Sodium Injection Sales Quantity by Type (2021-2032)
5.2 Global Cloprostenol Sodium Injection Consumption Value by Type (2021-2032)
5.3 Global Cloprostenol Sodium Injection Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Cloprostenol Sodium Injection Sales Quantity by Application (2021-2032)
6.2 Global Cloprostenol Sodium Injection Consumption Value by Application (2021-2032)
6.3 Global Cloprostenol Sodium Injection Average Price by Application (2021-2032)

7 North America

7.1 North America Cloprostenol Sodium Injection Sales Quantity by Type (2021-2032)
7.2 North America Cloprostenol Sodium Injection Sales Quantity by Application (2021-2032)
7.3 North America Cloprostenol Sodium Injection Market Size by Country
- 7.3.1 North America Cloprostenol Sodium Injection Sales Quantity by Country (2021-2032)
- 7.3.2 North America Cloprostenol Sodium Injection Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Cloprostenol Sodium Injection Sales Quantity by Type (2021-2032)
8.2 Europe Cloprostenol Sodium Injection Sales Quantity by Application (2021-2032)
8.3 Europe Cloprostenol Sodium Injection Market Size by Country
- 8.3.1 Europe Cloprostenol Sodium Injection Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Cloprostenol Sodium Injection Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Cloprostenol Sodium Injection Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Cloprostenol Sodium Injection Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Cloprostenol Sodium Injection Market Size by Region
- 9.3.1 Asia-Pacific Cloprostenol Sodium Injection Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Cloprostenol Sodium Injection Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Cloprostenol Sodium Injection Sales Quantity by Type (2021-2032)
10.2 South America Cloprostenol Sodium Injection Sales Quantity by Application (2021-2032)
10.3 South America Cloprostenol Sodium Injection Market Size by Country
- 10.3.1 South America Cloprostenol Sodium Injection Sales Quantity by Country (2021-2032)
- 10.3.2 South America Cloprostenol Sodium Injection Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Cloprostenol Sodium Injection Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Cloprostenol Sodium Injection Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Cloprostenol Sodium Injection Market Size by Country
- 11.3.1 Middle East & Africa Cloprostenol Sodium Injection Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Cloprostenol Sodium Injection Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Cloprostenol Sodium Injection Market Drivers
12.2 Cloprostenol Sodium Injection Market Restraints
12.3 Cloprostenol Sodium Injection Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Cloprostenol Sodium Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cloprostenol Sodium Injection
13.3 Cloprostenol Sodium Injection Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Cloprostenol Sodium Injection Typical Distributors
14.3 Cloprostenol Sodium Injection Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Cloprostenol Sodium Injection market size was valued at US$ 239 million in 2025 and is forecast to a readjusted size of US$ 315 million by 2032 with a CAGR of 3.9% during review period.
Cloprostenol Sodium Injection is a veterinary hormonal preparation containing cloprostenol sodium, a prostaglandin F2α analogue. It induces luteolysis and regulates the reproductive cycle in animals, and is commonly used in cattle, swine, and horses for estrus synchronization, breeding management, parturition induction, and treatment of uterine disorders.
In 2025, the global production of Cloprostenol Sodium Injection reached 14.7 million units, with an average selling price of USD 15.8 per unit. Total production capacity was approximately 20 million units, and the industry gross margin was around 30%–40%. The cost structure consists of about 80% direct materials, 15% manufacturing overhead, and 5% labor. The industrial chain includes upstream suppliers of cloprostenol sodium API, excipients, glass vials, and stoppers, while downstream comprises farms, veterinary hospitals, and related end users.
This report is a detailed and comprehensive analysis for global Cloprostenol Sodium Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cloprostenol Sodium Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Cloprostenol Sodium Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Cloprostenol Sodium Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Cloprostenol Sodium Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cloprostenol Sodium Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cloprostenol Sodium Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Elanco, MSD, Biogénesis Bagó, Boehringer Ingelheim, VetPharma, Interchemie, Ningbo Second Hormone Factory, Ningbo Sansheng Biotechnology, Ginten Biotechnology, Ningbo CREATOR ANIMAL Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Cloprostenol Sodium Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
20ml/vial
100ml/vial
Others
Market segment by Specification
250 µg/mL
100 µg/mL
Market segment by Application
Cows
Ewes
Sows
Others
Major players covered
Elanco
MSD
Biogénesis Bagó
Boehringer Ingelheim
VetPharma
Interchemie
Ningbo Second Hormone Factory
Ningbo Sansheng Biotechnology
Ginten Biotechnology
Ningbo CREATOR ANIMAL Pharmaceutical
TIEN (Tianjin) Pharmaceutical Co., Ltd.
Qilu Animal Health Products
Hefei Xinkexin Animal Pharmaceutical
Jiangxi Bolai Pharmacy
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cloprostenol Sodium Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cloprostenol Sodium Injection, with price, sales quantity, revenue, and global market share of Cloprostenol Sodium Injection from 2021 to 2026.
Chapter 3, the Cloprostenol Sodium Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cloprostenol Sodium Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Cloprostenol Sodium Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cloprostenol Sodium Injection.
Chapter 14 and 15, to describe Cloprostenol Sodium Injection sales channel, distributors, customers, research findings and conclusion.

Buy now